Pfizer Ltd Share Price

Pfizer joins hands with Mylan to expand Ativan and Pacitane reach in India

Pfizer Ltd has signed a five-year marketing and supply agreement with Mylan Pharmaceuticals to boost the distribution of its well-known brands, Ativan and Pacitane, in India. Ativan is widely used for anxiety disorders, while Pacitane is prescribed for Parkinson’s disease and neurological conditions. Mylan, with its strong presence in the central nervous system therapy segment, will leverage its network and specialist engagement to expand the reach of these products. This collaboration aims to enhance Pfizer’s in-clinic presence by tapping into Mylan’s expertise in working with neurologists and psychiatrists. While financial details remain undisclosed, both companies have finalized commercial arrangements. The agreement is exclusive to the Indian market and does not involve any joint venture or share exchange.

Pfizer Shares Extend Winning Streak as Quant Mutual Fund Raises Stake

Pfizer shares extended gains for a third straight session after Quant Mutual Fund acquired a ₹131.25 crore stake in the company. Pfizer Limited

High delivery stock

Symbol Delivered Qty ASTERDM 62324493 APOLLOTYRE 1551426 RAILTEL 1004625 ATGL 1378460 HSCL 7592497 AIIL 443706 JUBLPHARMA 712444 GLAXO 438502 SWIGGY 8661820 PFIZER 111827 SOBHA 109386 IGL 1962541 PFOCUS 884325 AADHARHFC 670510

The India-listed shares of Pfizer Limited have shown active momentum, closing at ₹4,874.80

Major Products and TreatmentsThe company owns several high-profile medicines and vaccines used globally

Pfizer Inc. is a leading American multinational pharmaceutical and biotechnology corporation headquartered in New York City